Yeah, that was hard to listen to. Imagine dragging out a vote from seven years ago like it still applies, completely ignoring the 95% drop, endless dilution, and everything that’s changed since!!!
But to be fair, there have been a few positives. The recent clinical progress is solid, the FDA fast track was a real win, and some of the preclinical data is actually starting to look promising. There’s still potential here!!!!
IMU Price at posting:
1.9¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)